Tobacco News and Research

RSS

FDA initiates NTSO actions for retailers who violated certain restrictions on sale of tobacco products

This week the U.S. Food and Drug Administration filed complaints initiating the first-ever No-Tobacco-Sale Order (NTSO) actions for a group of retailers who have repeatedly violated certain restrictions on the sale and distribution of tobacco products, including sales to minors. Under the law, the FDA may pursue an NTSO against retailers that have a total of five or more repeated violations of those restrictions during compliance inspections within 36 months.

31 Oct 2015

Web-based app helps women to maintain good health long before pregnancy

Women need to maintain good health years before they become pregnant. After all, healthy women are most likely to give birth to healthy babies.

30 Oct 2015

Rising cigarette exercise taxes push consumers toward more danger

Increasing cigarette exercise taxes may have the unintended consequence of encouraging consumers to seek higher nicotine content and more dangerous cigarette products, according to a study published in Marketing Science, a journal of the Institute for Operations Research and the Management Sciences.

29 Oct 2015

ASH study shows excessive smoking contributes to ongoing poverty in West Midlands

New figures from Action on Smoking and Health show that of the 513,000 households in the West Midlands that include an adult smoker 172,000 (34%) are below the poverty line.

29 Oct 2015

Researchers working to improve health and physical performance of soldiers

Researchers from around the world are working to improve soldiers' health and physical performance and health--with the goal of increasing military readiness and effectiveness, according to the November special issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

29 Oct 2015

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

29 Oct 2015

Study finds overall decreasing trend in leading causes of death

An analysis of deaths in the United States between 1969 and 2013 finds an overall decreasing trend in the age-standardized death rate for all causes combined and for heart disease, cancer, stroke, unintentional injuries, and diabetes, although the rate of decrease appears to have slowed for heart disease, stroke, and diabetes, according to a study in the October 27 issue of JAMA.

28 Oct 2015

Imlygic approved for treatment of melanoma lesions in the skin and lymph nodes

The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes.

28 Oct 2015

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

InComm, a leading prepaid product and transaction services company, and Pursuant Health (formerly SoloHealth) announced today a partnership to allow health plans to promote health risk assessments (HRAs) at Pursuant Health kiosks in Walmart stores. Health plans will be able to issue their members branded incentive cards with healthy rewards as part of the completion of the HRA.

27 Oct 2015

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic).

24 Oct 2015

Strensiq approved for treatment of patients with juvenile-onset HPP

Today, the U.S. Food and Drug Administration approved Strensiq (asfotase alfa) as the first approved treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP).

24 Oct 2015

New combination treatment approved by FDA for metastatic pancreatic cancer

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy.

23 Oct 2015

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Henry Ford Hospital pulmonologist Daniel Ouellette, M.D., who during his 31-year career in medicine has seen the harmful effects of smoking on his patients, advocates for raising the smoking age to 21.

22 Oct 2015

UF Health researcher reveals how betel nut's psychoactive chemical works in the brain

For hundreds of millions of people around the world, chewing betel nut produces a cheap, quick high but also raises the risk of addiction and oral cancer. Now, new findings by a University of Florida Health researcher reveal how the nut's psychoactive chemical works in the brain and suggest that an addiction treatment may already exist.

22 Oct 2015

Veltassa (patiromer for oral suspension) gets FDA approval for treatment of hyperkalemia

The U.S. Food and Drug Administration today approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.

22 Oct 2015

Coagadex now approved by FDA for patients with hereditary Factor X deficiency

The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today's orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.

21 Oct 2015

Pediatricians to discuss children's health issues at AAP National Conference & Exhibition

An expected 10,000 pediatricians and other health care professionals will gather in the nation's capital October 24-27 to deepen their knowledge and widen their scope on child advocacy at the American Academy of Pediatrics National Conference & Exhibition.

19 Oct 2015

FDA grants accelerated approval to Praxbind (idarucizumab)

The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa's blood-thinning effects.

19 Oct 2015

Tobacco-state politicians urged to focus on potential impact of TPP trade agreement

If Republican senators from tobacco-growing southern states believe in social responsibility, they would fully explore the TransPacific (TPP) trade agreement's potential impact on countries around the world — including provisions that influence the ability of American tobacco corporations to flood the globe with cheap, cancer-causing cigarettes — suggests the author of a book on the history, social costs and global politics of the tobacco industry.

19 Oct 2015

WSU scientist wins federal grant to explore metabolism pathways, tobacco carcinogens

A Washington State University researcher has received a $2.6 million federal grant to study the body's ability to keep tobacco smoke components from causing cancer.

16 Oct 2015

Tobacco News and Research

FDA initiates NTSO actions for retailers who violated certain restrictions on sale of tobacco products

Web-based app helps women to maintain good health long before pregnancy

Rising cigarette exercise taxes push consumers toward more danger

ASH study shows excessive smoking contributes to ongoing poverty in West Midlands

Researchers working to improve health and physical performance of soldiers

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Study finds overall decreasing trend in leading causes of death

Imlygic approved for treatment of melanoma lesions in the skin and lymph nodes

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

Strensiq approved for treatment of patients with juvenile-onset HPP

New combination treatment approved by FDA for metastatic pancreatic cancer

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

UF Health researcher reveals how betel nut's psychoactive chemical works in the brain

Veltassa (patiromer for oral suspension) gets FDA approval for treatment of hyperkalemia

Coagadex now approved by FDA for patients with hereditary Factor X deficiency

Pediatricians to discuss children's health issues at AAP National Conference & Exhibition

FDA grants accelerated approval to Praxbind (idarucizumab)

Tobacco-state politicians urged to focus on potential impact of TPP trade agreement

WSU scientist wins federal grant to explore metabolism pathways, tobacco carcinogens

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News